Oxford Brain Diagnostics Set to Revolutionize Dementia Diagnosis
Oxford, UK — Oxford Brain Diagnostics (OBD) is on the verge of transforming dementia diagnosis with the upcoming launch of its innovative Cortical Disarray Measurement (CDM) software in the UK and US healthcare markets. The firm has recently secured FDA 510(k) clearance and UKCA self-certification, marking a pivotal moment in its growth.
Backed by BGF, a leading growth capital investor, OBD’s CDM software offers an objective and non-invasive method to measure neurodegeneration using standard MRI scans, providing more accurate and earlier assessments of brain health. "Neurodegenerative diseases represent a growing public health challenge," said Dr. Steven Chance, CEO and co-founder of OBD. "Our technology brings hope to millions seeking clarity on their brain health."
Co-founded in 2019 by Dr. Chance and Professor Mark Jenkinson, an expert in neuroimaging, OBD’s CDM platform draws on extensive research into structural brain changes related to Alzheimer’s and other neurodegenerative conditions. The FDA’s 2020 Breakthrough Device Designation highlighted its potential in early-stage Alzheimer’s detection.
Recently, a multi-million-pound funding round, led by BGF, has fueled OBD’s commercial efforts, enabling strategic partnerships with pharmaceutical companies to support clinical trials and drug development.
As the demand for accurate diagnostic tools increases—especially with the anticipated rise in Alzheimer’s treatments—OBD is well-positioned to fill this crucial gap. While focused initially on Alzheimer’s, the technology’s applications may extend to other neurodegenerative diseases like Parkinson’s and Multiple Sclerosis.
With dementia cases expected to double every two decades, early and precise diagnostics have never been more vital. OBD’s launch could dramatically shift the landscape of brain health evaluation and treatment, moving towards proactive, data-driven care for patients worldwide.
Note: The image is for illustrative purposes only and is not the original image associated with the presented article. Due to copyright reasons, we are unable to use the original images. However, you can still enjoy the accurate and up-to-date content and information provided.]
